These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
459 related items for PubMed ID: 19922023
1. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Hu N, Long H, Zhao M, Yin H, Lu Q. Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023 [Abstract] [Full Text] [Related]
2. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N. J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948 [Abstract] [Full Text] [Related]
3. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B. J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157 [Abstract] [Full Text] [Related]
4. Abnormal histone modification patterns in lupus CD4+ T cells. Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W, Zhang G, Zhou Y, Su Y, Lu Q. J Rheumatol; 2008 May; 35(5):804-10. PubMed ID: 18398941 [Abstract] [Full Text] [Related]
5. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S. J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [Abstract] [Full Text] [Related]
6. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Dieker JW, Fransen JH, van Bavel CC, Briand JP, Jacobs CW, Muller S, Berden JH, van der Vlag J. Arthritis Rheum; 2007 Jun; 56(6):1921-33. PubMed ID: 17530637 [Abstract] [Full Text] [Related]
7. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice]. Zhai ZF, Zhou CL, Zhong BY, Ao JH, Hao F. Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):406-10. PubMed ID: 18581896 [Abstract] [Full Text] [Related]
8. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A. Arthritis Rheum; 2002 Nov 05; 46(11):3083-95. PubMed ID: 12428253 [Abstract] [Full Text] [Related]
9. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC. J Am Soc Nephrol; 2005 Dec 05; 16(12):3572-82. PubMed ID: 16207826 [Abstract] [Full Text] [Related]
10. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice. Song YC, Tang SJ, Lee TP, Hung WC, Lin SC, Tsai CY, Ng WV, Wu MF, Sun KH. Arthritis Rheum; 2010 Aug 05; 62(8):2401-11. PubMed ID: 20506162 [Abstract] [Full Text] [Related]
11. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. Fujii T, Okada M, Fujita Y, Sato T, Tanaka M, Usui T, Umehara H, Mimori T. J Autoimmun; 2009 Sep 05; 33(2):125-34. PubMed ID: 19596182 [Abstract] [Full Text] [Related]
12. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. J Clin Invest; 2003 Feb 05; 111(4):539-52. PubMed ID: 12588892 [Abstract] [Full Text] [Related]
13. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice. Lu Q, Shen N, Li XM, Chen SL. Genes Immun; 2007 Oct 05; 8(7):590-603. PubMed ID: 17728792 [Abstract] [Full Text] [Related]
14. Macrophages from lupus-prone MRL mice are characterized by abnormalities in Rho activity, cytoskeletal organization, and adhesiveness to extracellular matrix proteins. Longacre A, Koh JS, Hsiao KK, Gilligan H, Fan H, Patel VA, Levine JS. J Leukoc Biol; 2004 Nov 05; 76(5):971-84. PubMed ID: 15316033 [Abstract] [Full Text] [Related]
15. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U. J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217 [Abstract] [Full Text] [Related]
16. Role of inducible costimulator in the development of lupus in MRL/lpr mice. Tada Y, Koarada S, Tomiyoshi Y, Morito F, Mitamura M, Haruta Y, Ohta A, Nagasawa K. Clin Immunol; 2006 Aug 01; 120(2):179-88. PubMed ID: 16616645 [Abstract] [Full Text] [Related]
17. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H. Arthritis Rheum; 2005 Jan 01; 52(1):94-104. PubMed ID: 15641079 [Abstract] [Full Text] [Related]
18. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ. J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978 [Abstract] [Full Text] [Related]
19. Abnormal expression pattern of histone demethylases in CD4(+) T cells of MRL/lpr lupus-like mice. Long H, Huang W, Yin H, Zhao S, Zhao M, Lu Q. Lupus; 2009 Dec 15; 18(14):1327-8. PubMed ID: 19850659 [No Abstract] [Full Text] [Related]
20. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus. Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S. Mol Immunol; 2013 Dec 15; 56(4):574-82. PubMed ID: 23911415 [Abstract] [Full Text] [Related] Page: [Next] [New Search]